Redmile Private Investments II, L.P. - Oct 5, 2020 Form 3 Insider Report for Augmedix, Inc. (AUGX)

Role
Director, 10%+ Owner
Signature
By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC, Managing Member of Redmile Private Investments II (GP), LLC, General Partner of Redmile Private Investments II, L.P.
Stock symbol
AUGX
Transactions as of
Oct 5, 2020
Transactions value $
$0
Form type
3
Date filed
4/21/2023, 09:52 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AUGX Common Stock 4.59M Oct 5, 2020 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AUGX Common Stock Warrant (right to buy) Oct 5, 2020 Common Stock 917K $1.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A Form 3 was previously filed on October 7, 2020 by Redmile Group, LLC ("Redmile"), the investment manager of Redmile Private Investments II, L.P., which reported Redmile's indirect ownership of the Common Stock and Common Stock Warrants reported herein.

Remarks:

As of the date of the event requiring this Form 3, Gerard van Hamel Platerink, a managing director of Redmile, was a member of the Issuer's board of directors as a representative of Redmile. Mr. van Hamel Platerink resigned from the board effective as of September 2, 2022. On April 14, 2023, Rob Faulkner, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile and its affiliates. As a result, Redmile and the reporting person are deemed to be directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.